Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRICKLE1 antisense RNA 1 (PRICKLE1-AS1) is a non-coding RNA gene transcribed from the antisense strand at or near the PRICKLE1 gene locus. Antisense RNAs are often involved in the regulation of their associated sense transcripts, typically by mechanisms such as transcriptional interference, RNA duplex formation, or influencing chromatin structure. However, for PRICKLE1-AS1, its biological functions, roles in signaling, disease involvement, or utility as a therapeutic target have not yet been established in the scientific literature[9][10]. If you require information on PRICKLE1 itself (the protein-coding gene), substantial evidence supports its functions in cell polarity, Wnt signaling, and neurological development, and it has documented roles in epilepsy and cancer, making it a possible therapeutic target[1][3][5][7]. However, PRICKLE1-AS1 specifically is a non-coding RNA with currently unknown function and no established therapeutic relevance.
Not established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRICKLE1 antisense RNA 1 (PRICKLE1-AS1).